期刊文献+

降钙素原检测在感染合并心力衰竭患者诊断中的意义探讨 被引量:1

下载PDF
导出
摘要 目的分析降钙素原检测在感染合并心力衰竭患者诊断中的意义。方法以2013年1月—2016年1月在我院接受诊治的90心力衰竭患者作为研究对象,根据是否出现合并感染症状将患者分为感染组(n=50)和未感染的对照组(n=40),对2组患者入院接受治疗前后的血清降钙素原水平进行检测。结果治疗前,感染组血清降钙素原平均浓度明显高于对照组,在血清降钙素原浓度差分别为<2.0 ng/m L和≥2.0ng/m L时,2组患者的血清降钙素原浓度在各级别中的比例差异明显,感染组以浓度≥2.0 ng/m L居多(60.0%),对照组以浓度<2.0 ng/m L居多(67.5%),差异具有统计学意义(P<0.05);恢复期,予以抗生素治疗的感染组患者血清降钙素原浓度同对照组相比,差异无统计学意义(P>0.05)。结论血清降钙素原是心力衰竭患者合并感染情况诊断的有效指标,值得临床推广应用。
作者 姚元超
机构地区 贵州航天医院
出处 《基层医学论坛》 2017年第22期2973-2974,共2页 The Medical Forum
  • 相关文献

参考文献4

二级参考文献43

  • 1Elenius V, Peltola V, Ruuskanen O, et al. Plasma procalcitonin levels in children with adenovirus infection [ J ]. Arch Dis Child,2012, 97:582-583.
  • 2Fletcher AE, Hunt BM, Bulpitt CJ. Evaluation of quality of life in clinical trials of cardiovascular disease[ J]. J Chronic Dis, 1987, 40:557-569.
  • 3Meisner M, Lohs T, Huettemann E, et al. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function[J]. EurJ Anaesthesiol, 2001, 18:79-87.
  • 4Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[ Jl. JAMA, 2009, 302 : 1059-1066.
  • 5Bottner F, Wegner A, Winkelmann W, et al. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement[ J]. J Bone Joint Surg Br, 2007, 89:94-99.
  • 6Sandek A, Springer J, Habedank D, et al. Procalcitonin-guided antibiotic treatment in heart failure [ J ]. Lancet, 2004, 363 : 1555.
  • 7Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions:a systematic review of randomized controlled trails and recommendations for clinical algorithms [ J]. Arch Intern Med, 2011, 171:1322-1331.
  • 8Giamarellos-Bourboulis EJ, Mega A, Greeka P, et al. A marker to clearly differentiate syatemic inflammatory response syndrome and sepsis in the critically ill patient? [ J]. Intensive Care Med, 2002, 28 : 1351-1356.
  • 9Lee NS, Daniels LB. Personalized CHF treatment: PCT to guide therapy in heart failure patients [J]. Int J Cardiol, 2014, 176(2): 307-308.
  • 10Schuetz P, Kutz A, Grolimund E, et al. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial [J]. Int J Cardiol, 2014, 175(3): 464-472.

共引文献31

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部